Products for Research Use Only
RegisterLogin

CEP37440

CAT: 0013-GTR19160542-01Size: 200 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19160542-01Size:200 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CEP-37440 is an orally available dual kinase inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) and focal adhesion kinase (FAK), with potential antineoplastic activity. Upon administration, ALK-FAK inhibitor CEP-37440 selectively binds to and inhibits ALK kinase and FAK kinase. The inhibition leads to disruption of ALK- and FAK-mediated signal transduction pathways and eventually inhibits tumor cell growth in ALK- and FAK-overexpressing tumor cells. ALK belongs to the insulin receptor superfamily and plays an important role in nervous system development; its dysregulation and gene rearrangements are associated with a variety of tumors.
CAS Number
1391712-60-9
Product Name Alternative
CEP37440 | CEP 37440 | CEP-37440
Purity
>98% (HPLC)
Solubility
DMSO : ≥ 41 mg/mL. 70.68 mM
Smiles
CNC (=O) c1ccccc1Nc1nc (ncc1Cl) Nc1c (c2c (C[C@H] (CCC2) N2CCN (CC2) CCO) cc1) OC
Molecular Formula
C30H38ClN7O3
Molecular Weight
580.12
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
(S) -2- ((5-chloro-2- ((6- (4- (2-hydroxyethyl) piperazin-1-yl) -1-methoxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl) amino) pyrimidin-4-yl) amino) -N-methylbenzamide

Alternative Products

CatalogName
M17273-01CEP37440

Popular Products